Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flortaucipir F 18 Screening in Early Symptomatic AD
NCT03322462Phase 2Completed
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Nov 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of flortaucipir in Alzheimer's disease (AD), sponsored by Avid Radiopharmaceuticals. Started Nov 2017; status: completed.
02
Drugs
flortaucipir
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03322462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03322462.